Publicerad: 2020-10-13 17:16 | Uppdaterad: 2020-10-14 10:27

Aktuella utlysningar, vecka 42, 2020

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Kerstin Hejdenbergs stipendium

Kerstin Hejdenberg var under 90-talet ordförande för såväl Astma- och Allergiförbundet som dess forskningsfond. Vid hennes bortgång 2000 inrättades en minnesfond som varje år delar ut stipendier till doktorander inom barnallergologisk forskning.

Stipendiets ändamål är att uppmuntra forskning om psykologiska och sociala dimensioner i den allergiska sjukdomen, samt prioritera forskning som kan leda till förbättrad kommunikation mellan vårdpersonal och patient, och fonden stöder gärna tvärvetenskaplig forskning.

Closing date: Ansökningstiden är fr.o.m. den 1 oktober till den 31 oktober 2020. Ansökan görs via ett webbformulär som du hittar på www.allergiforskning.se under fliken ”KH stipendium”.

Further information

Anslag till medicinsk forskning – Stiftelsen Apotekare Hedbergs Fond för medicinsk forskning

Stiftelsen Apotekare Hedbergs Foundation for Medical support advanced medical research in Sweden. Projects relating to clinical research in the field of inflammatory diseases are given priority. The total budget is at least SEK 500,000 and is divided between a maximum of eight applicants.

Closing date:16 November 2020

Further information

Initiation Grants for Internationalisation, Africa – Swedish Foundation for International Cooperation in Research and Higher Education (STINT)

Globally, more and more countries offer high-quality research and education. This is a call for applications for mobility grants to develop new academic partnerships with higher education institutions in Africa, in the areas of research and/or higher education. The call is aimed at projects spanning up to a year. Collaborations must be balanced and lead to mutual benefits and mobility in both directions. The main partner must be in Africa. Since several ongoing activities are already related to collaborations with South Africa, we particularly welcome applications regarding collaborations with other African countries.

Closing date: 20 November 2020

Further information

Forskningsstipendier – Insamlingsstiftelsen Kvinnor och Hälsa

Forskningsstipendier från Stiftelsen Kvinnor & Hälsa på 300.000 SEK till forskare som ska eller just har disputerat och som driver genusmedicinsk forskning inom hjärt-kärlsjukdom utifrån biologiska och psyko-sociala aspekter.

Forskningsstipendier på 110.000 SEK till forskare som ska eller just har disputerat inom gynekologisk cancer.

Closing date: 23 November 2020

Further information

Forskningsstipendier till minne av Anna Söderberg – Insamlingsstiftelsen Kvinnor och Hälsa

Insamlingsstiftelsen Kvinnor och Hälsa och 1,6 miljonerkluggen inbjuder ansökningar om forskningsstipendier till minne av Anna Söderberg. Dessa stöder forskning om endometrios och hjärtkärlsjukdomar som drabbar gravida kvinnor. Två stipendier, värda SEK 100,000 var, finns tillgängliga.

Closing date: 23 November 2020

Further information

Projekt- och reseanslag för medicinsk forskning – Eva och Oscar Ahréns Stiftelse

Eva och Oscar Ahréns Stiftelse inbjuder ansökningar om projekt- och reseanslag för medicinsk forskning. Dessa främjar vetenskaplig, företrädesvis medicinsk forskning, samt stöd till studieresor. Vid ansökan om resebidrag har forskare vid Karolinska institutet företräde. Unga forskare prioriteras i ansökan om projektanslag. Projektanslag uppgår till högst SEK 100,000 under två år. Resebidrag gäller under två år.

Closing date: 31 January 2021

Further information

Europeiska utlysningar

Fight kids cancer programme - Imagine for Margo – Children without Cancer

Imagine for Margo – Children without Cancer, KickCancer and Fondatioun Kriibskrank Kanner invite applications for their fight kids cancer programme. This aims to catalyse and support pan-European innovative and relevant research initiatives in paediatric cancer. Projects may aim to develop new therapies that improve the outcome for all children and adolescents with cancer. There are two categories of projects: early phase clinical trials conducted in at least two countries, and translation research projects to identify novel mechanisms of action and targets that may result in innovative new therapies or better models of disease. Pre-clinical projects including high-risk/high return proposals, or projects that leverage paediatric tumour models, will be considered. Multi-disciplinary or multi-institution collaborations are strongly encouraged.

Closing date (Expression of Interest ): 6 December 2020

Further information

EXTENDED DEADLINE:
European Cooperation in Science and Technology (COST) - European Cooperation in Science and Technology

The European Cooperation in Science and Technology (COST) invites proposals for its action call. This supports networking activities such as meetings, short-term scientific missions, training schools and dissemination activities in the areas of science and technology. The aim is to foster the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe.

Closing date: 13 November 2020

Further information

Research grants - European Hematology Association

The European Hematology Association invites applications for its research grants. These enable early-career researchers in the field of haematology to advance their career towards becoming the leader of a research group. Research must be basic or translational lab-based research. 

Closing date: 16 December 2020

Further information

Eppendorf award for young European investigators - Eppendorf AG

The Eppendorf AG, in partnership with the scientific journal Nature, invites applications for its award for young European investigators. This recognises contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.

Closing date: 15 January 2021

Further information

Project funding - Robert Bosch Stiftung

The Robert Bosch Stiftung invites applications for its project funding This supports projects in the following fields: education; civil society; health; international communication and co-operation; science.

Closing date: No deadline

Further information

Amerikanska utlysningar

Federal Funding agencies

HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed), NIH

Purpose: The goals of this Funding Opportunity Announcement (FOA) are to stimulate further research on delineating the pathophysiology of HIV-1 associated CNS disease in the setting of chronic viral suppression and ART. In addition, FOA also encourages research studies to aid in the identification/ validation of biomarkers and pre-clinical targets with quantifiable readouts in domestic and international settings. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Closing date: Standard AIDS dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-20-149

Further information 

Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed), NIH

Purpose: This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Closing date: Standard AIDS dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-20-151

Further information 

Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed), NIH

Purpose: This Funding Opportunity Announcement (FOA) solicits R01 grant applications to develop novel technologies that will enable substantive (no less than one order of magnitude) improvement in synthetic nucleic acids. The goal is to improve the quality, capabilities and efficiency of nucleic acid synthesis and synthetic constructs at reasonable and decreased costs. Large progress in this area has the potential to catalyze scientific advances relevant to the mission of NIH, NHGRI and the field of genomics.

Closing date: June 24, 2020; March 9, 2021; February 4, 2022

Funding Opportunity Announcement (FOA): RFA-HG-20-014 (R01), RFA-HG-20-015 (R21)

Further information (R01)

Further information (R21)

 

Foundation

Aligning science across Parkinson’s collaborative research network, Michael J Fox Foundation for Parkinson's Research, US

The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson’s (ASAP) initiative being implemented through The Michael J. Fox Foundation, seeks to support multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression.  This program solely funds basic research aimed at understanding the 1) structure and function of the nervous system (and related physiological systems) and 2) disease mechanisms that contribute to Parkinson’s disease. Research can involve studies performed in vitro, in animals or in humans.

Eligibility: Core Leadership – Each Team must consist of a minimum of three (3) to a maximum of five (5) PIs. A Coordinating Lead PI must be appointed for each Team, who will be responsible for overall project management and reporting to ASAP/MJFF staff. Team structure and management is discussed in further detail below.
Career Stage & Disciplines Represented – We require the Core Leadership for each Team to consist of at least one (1) early career investigator in the position of Co-I, and for there to be at least two (2) different disciplines represented on each Team. 
• Institutions – There must be a minimum of two (2), but no more than five (5) participating institutions represented by the Team.
Degree – All Core Leadership must hold a doctorate, such as a PhD, MD, or equivalent degree.
Appointment – The Coordinating Lead PI must have an academic appointment and be in an independent faculty position or equivalent. All other Core Leadership must be in an independent faculty position or equivalent.
• Time Allocation – All Core Leadership are expected to allocate a minimum of 25% time and effort to the research project.
Budget: Up to $9 million (requests should not exceed $3 million per year) for three-year grants

Closing date: December 11, 2020 (Pre-proposal deadline), April 13, 2021 (Full proposal deadline by invitation only)

Further information 

Research grants, Progeria Research Foundation, US

The Progeria Research Foundation (PRF) is a driving force worldwide in finding treatments and the cure for Progeria and its aging-related disorders, including heart disease.  We invite qualified scientists with faculty appointments or the equivalent to submit applications for the 2021 grant cycle. Research Focus: PRF’s research focus is highly translational. Topics must fall within the following

Research priorities:
1. Projects that are likely to lead to clinical treatment trials within 5 years. This includes the discovery and/or testing of candidate treatment compounds in cellbased or animal models of HGPS. Only proposals that test compounds in a progerin-producing animal or cell model will normally be considered. Analyses in non progerin-producing models are acceptable, but only as a comparison to progerin-producing models and with strong justification.
2. Development of gene-, biomolecule-, drug-, and cell-based therapies to treat Progeria
3. Assessment of natural history of disease that may be important to developing outcome measures in treatment trials (preclinical or clinical)
Award Details:
A. Phase I Proposals:
Awards are typically for 1-2 years at a maximum of $75,000/year.
B. Phase II Proposals: Phase I investigators may be invited to submit a follow-up Phase II grant proposal. These Phase II Grant proposals are generally by invitation only. They will be reviewed on the regularly scheduled grant review meeting dates. Award durations: Standard Awards can be up to 3 years. Fellowship Awards can be up to 2 years.
Eligibility:  
A. For Phase I proposals, Letters of Intent must be submitted to PRF and submission invitations must be extended by PRF prior to submission of full proposals.
B. Principal Investigators must hold faculty appointments or equivalent at institutions with 501(c)(3) taxexempt status, or the equivalent for foreign institutions. Co-Principal Investigators are allowed.
C. Proposed projects must have specific relevance to HGPS and show promise for contributing to the scientific or clinical advancement in this field of study (see Research Focus in item II).

Closing date: January 4, 2021 (Letter of Intent), April 1, 2021, due by 5pm U.S. Eastern Standard Time  (Full application by invitation)

Further information